George King was elected president of NHF.

For many patients, at-home care becomes a reality thanks to the industrial manufacturing and commercial availability of freeze-dried plasma concentrates of FVIII for HA and of the coagulation factors (II, VII, IX, X).

The Great Lakes Hemophilia Foundation becomes an NHF chapter. The chapter was founded in part by Dr. Jacob (Jay) Shanberge, the director of pathology and laboratory medicine at Mt. Sinai Hospital in Milwaukee.

NHF advocacy helps the state of Illinois dedicate $500,000 in public funding toward hemophilia assistance.

NHF advocates partner with Senator Harrison Williams of New Jersey to sponsor Senate Bill 1326, the Hemophilia Act of 1973, which ultimately passes in 1975. The bill eatabliahes $3M toward a hemophilia treatment center program nationwide.

On Nov. 15, 1973, a diverse group of NHF advocates met before the Senate Committee on Labor and Public Welfare to testify and advocate for the funding of diagnosis and treatment centers.

The National Heart, Blood Vessel, Lung, and Blood Act of 1972 (P.L. 92-423) enlarged institute authority to advance the national attack on heart, blood vessel, lung, and blood diseases. The act provided for expanded, intensified, and coordinated institute activities in accordance with a comprehensive, specified National Heart, Blood Vessel, Lung, and Blood Disease Program to be planned by the director and the Advisory Council.

It also called for establishment of prevention and control programs; development of 15 new centers for basic and clinical research, training, demonstration, and prevention programs for heart, blood vessel, and blood diseases; and development of 15 such centers for chronic lung diseases.

Thanks to NHF advocacy, Pennsylvania dedicates $2M to hemophilia treatment centers.

NHF launches the Judith Graham Pool Research Fellowship.

Dr. Oscar Ratnoff and his colleagues at Case Western University publish their findings on an immunulogical assay test that can identify female carriers of hemophilia.